The information on this site is intended to supplement and enhance, not replace, the advice of a physician who is familiar with your medical history. Decisions about your health should always be made ONLY after detailed conversation with your doctor.
Generic drug name:
ipratropium
(ip ra TROP ee um)
Brand name(s):
ATROVENT
GENERIC:
not available
FAMILIES:
Beta Agonists, Drugs for Chronic Obstructive Pulmonary (Lung) Disease (COPD)
Find the drug label by
searching at DailyMed.
Generic drug name:
ipratropium and albuterol
(ip ra TROP ee um and al BYOO ter ol)
Brand name(s):
COMBIVENT,
DUONEB
GENERIC:
not available
FAMILIES:
Beta Agonists, Drugs for Chronic Obstructive Pulmonary (Lung) Disease (COPD)
Find the drug label by
searching at DailyMed.
Pregnancy and Breast-feeding Warnings [top]
Pregnancy Warning
Albuterol, a component of COMBIVENT, caused malformations in human infants. Because of the potential for serious adverse effects to the fetus, ipratropium with albuterol should not be used by pregnant women. There were no adverse effects seen in animal studies with ipratropium when used alone, and there were no human data.
Breast-Feeding Warning
No information is available from either human or animal studies. However, because many drugs are excreted in human milk, it is likely that these drugs are present in milk. Because of the potential for adverse effects in nursing infants, particularly the potential for cancer with albuterol, you should not take the combination of ipratropium and albuterol while nursing.
Safety Warnings For This Drug [top]
Anticholinergic Effects
Warning: Special Mental and Physical Adverse Effects
Older adults are especially sensitive to the harmful anticholinergic effects of these drugs. Drugs in this family should not be used unless absolutely necessary.
Mental Effects: confusion, delirium, short-term memory problems, disorientation and impaired attention
Physical Effects: dry mouth, constipation, difficulty urinating (especially for a man with an enlarged prostate), blurred vision, decreased sweating with increased body temperature, sexual dysfunction and worsening of glaucoma
Facts About This Drug [top]
Ipratropium (ATROVENT) is approved by the Food and Drug Administration (FDA) for the management of chronic obstructive pulmonary disease (COPD). It is not approved for the treatment of asthma.[1] An anticholinergic drug in the same family as atropine,[2] ipratropium takes about 15 minutes to work and lasts about three to six hours.
Ipratropium enlarges the bronchial tubes but may also enlarge the intestines.[3] It does not control symptoms nor reduce inflammation, a drawback for treating...
Ipratropium (ATROVENT) is approved by the Food and Drug Administration (FDA) for the management of chronic obstructive pulmonary disease (COPD). It is not approved for the treatment of asthma.[1] An anticholinergic drug in the same family as atropine,[2] ipratropium takes about 15 minutes to work and lasts about three to six hours.
Ipratropium enlarges the bronchial tubes but may also enlarge the intestines.[3] It does not control symptoms nor reduce inflammation, a drawback for treating asthma according to a report of the International Asthma Management Project.[4] It does not relieve nasal congestion or sneezing.
While ipratropium is often preferred for use in people over age 60, it should be used cautiously in older men with prostate problems.[5]
COMBIVENT is a combination of ipratropium with the beta agonist bronchodilator albuterol (PROVENTIL).
Side effects
Ipratropium may thicken secretions in the lungs, cause retention of urine and cause or worsen narrow-angle glaucoma.
Acute urinary retention (AUR)
An Archives of Internal Medicine study suggested that older men with COPD and being treated with the commonly used inhaled anticholinergic bronchodilator drugs containing ipratropium (ATROVENT, COMBIVENT and DUONEB) and tiotropium (SPIRIVA) are at increased risk of AUR, a condition characterized by a sudden inability to urinate.
AUR is considered a medical emergency and can cause bladder damage, urinary tract infections, sepsis, kidney failure and death unless promptly treated. The risk of developing this adverse effect appears to be greatest in men with benign prostatic hypertrophy (BPH), or enlarged prostate.
The study, published on May 23, 2011, highlighted the fact that inhaled medications used to treat lung diseases such as COPD can have serious adverse effects on organs other than the lungs. Patients taking these drugs need to be aware of these side effects so that they can be alert for early symptoms.
Before You Use This Drug [top]
Tell your doctor if you have or have had:
Tell your doctor about any other drugs you take, including aspirin, herbs, vitamins, and other nonprescription products.
When You Use This Drug [top]
How to Use This Drug [top]
Interactions with Other Drugs [top]
The following drugs, biologics (e.g., vaccines, therapeutic antibodies), or foods are listed in Evaluations of Drug Interactions 2003 as causing “highly clinically significant” or “clinically significant” interactions when used together with any of the drugs in this section. In some sections with multiple drugs, the interaction may have been reported for one but not all drugs in this section, but we include the interaction because the drugs in this section are similar to one another. We have also included potentially serious interactions listed in the drug’s FDA-approved professional package insert or in published medical journal articles. There may be other drugs, especially those in the families of drugs listed below, that also will react with this drug to cause severe adverse effects. Make sure to tell your doctor and pharmacist the drugs you are taking and tell them if you are taking any of these interacting drugs:
cromolyn solution (if mixed with ipratropium a cloudy sludge will form; do not use such mixtures), GASTROCOM, INTAL, NASALCROM.
For albuterol: GLUCOPHAGE, GLUCOVANCE, METAGLIP, metformin.
Adverse Effects [top]
Call your doctor immediately if you experience:
Call your doctor if these symptoms continue:
last reviewed August 31, 2024